Reynoso Jamie L. sold $29K of CLOV
Reynoso Jamie L. (CEO, Medicare Advantage) sold 6,350 shares of CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) at $4.61 on 2026-06-15 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest concrete fact is the CEO’s open-market sale of 6,350 shares at $4.61, with a stated pre-arranged 10b5-1 plan.
Market read
This is a disclosed insider sale; it may slightly influence sentiment but lacks fundamental catalysts in the text.
What to watch
The filing provides no new guidance, trial, contract, or regulatory update—so traders should avoid extrapolating fundamentals from the sale alone.
Background
The article is an SEC Form 4 insider transaction disclosure for Clover Health Investments Corp./DE.
Ticker impact
Clover Health CEO Jamie L. Reynoso sold 6,350 shares in an open-market transaction at $4.61 on 2026-06-15 (Form 4).
Low likelihood of a sustained price move solely from this Form 4; any reaction would be short-lived unless accompanied by other catalysts.
The filing is an SEC Form 4 insider sale, but it explicitly states a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.
Market effects
Minimal read-through to the broader healthcare/Medicare Advantage sector; this is company-specific insider activity without new operational/regulatory facts.
None indicated.
None indicated.
Counterpoint
Insider sales on a 10b5-1 plan can be driven by liquidity/tax planning rather than bearish expectations, so the market may overreact if it treats it as discretionary.
Key entities
- issuerClover Health Investments Corp./DE
Subject of the Form 4 insider transaction disclosure.
- insiderJamie L. Reynoso
CEO, Medicare Advantage; reported open-market sale under a 10b5-1 plan.
